INKT   $9.57  4.93% Market Closed After Close 9.4087 -1.69%

MiNK Therapeutics, Inc.
Total Cash 9.31M
totalCashPerShare 0.236
EBITDA -17.25M
Total Debt 4.41M
quickRatio 0.918
currentRatio 0.934
Total Revenue
debtToEquity
Revenue/Share
ROA -0.97252
ROE
grossProfits
freeCashflow -8.16M
operatingCashflow -12.08M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 24.05M
forwardPE -1.7435714
floatShares 10.09M
sharesOutstanding 39.54M
sharesShort 65.34K
sharesShortPriorMonth 62.01K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.75%
heldPercentInstitutions 0.02%
Short Ratio help_outline 1.34%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.42
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -17.09M
trailingEps -0.48%
forwardEps -0.42%
enterpriseToEbitda -1.39
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.08 3Q 2024
institutionsCount 43
lastUpdated Nov. 7, 2024, 11:18 a.m.